Expression, genomic patterns predict sarcoma progression

January 18, 2013
Expression, genomic patterns predict sarcoma progression
The Complexity Index in Sarcoma and Genomic Index prognostic signatures are valid independent methods of assessing synovial sarcoma prognosis, according to a study published online Jan. 14 in the Journal of Clinical Oncology.

(HealthDay)—The Complexity Index in Sarcoma (CINSARC) and Genomic Index prognostic signatures are valid independent methods of assessing synovial sarcoma (SS) prognosis, according to a study published online Jan. 14 in the Journal of Clinical Oncology.

Pauline Lagarde, of the Institut Bergonié in Bordeaux, France, and colleagues examined whether expression and genomic prognostic signatures related to chromosome integrity in and (CINSARC and Genomic Index) could predict outcomes in SS. In a training/validation approach, 100 patients with primary untreated SS tumors underwent expression and genomic profiling.

The researchers found that CINSARC and Genomic Index exhibited significant independent and validated prognostic values. Fourteen genes in the CINSARC signature were identified through comparing of tumors with or without metastasis; and in an independent cohort, KIF14 and CDCA2, were validated as prognostic markers. Metastasis was associated with genome complexity in both adult and pediatric SS; the adult genome was more frequently rearranged, and, accordingly, metastasis did not develop in pediatric patients who had an even genomic profile.

"To conclude, this study offers results that are meaningful for understanding the metastatic potential of sarcomas in general, and particularly in SS for which this study provides a biologic explanation for the distinct aggressiveness of pediatric and adult SS," the authors write.

Explore further: Gene score IDs prognosis in metastatic neuroblastoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gene score IDs prognosis in metastatic neuroblastoma

August 29, 2012
(HealthDay)—For children with metastatic MYCN-nonamplified neuroblastoma (NBL-NA) diagnosed at age 18 months or older, increased expression of tumor-associated inflammatory genes seems to correlate with poor prognosis, ...

Post-laminectomy spine strength can be predicted

January 17, 2013
(HealthDay)—Following lumbar laminectomy, loss of strength and shear stiffness (SS) can be predicted in the human lumbar spinal segment using measurable parameters, according to a study published in the December issue of ...

PR+ cells add prognostic value in luminal A breast cancer

December 17, 2012
(HealthDay)—Semiquantitative immunohistochemical expression of progesterone receptor-positive tumor cells improves prediction of survival within luminal A breast cancers, according to a study published online Dec. 10 in ...

Telomere failure, telomerase activation drive prostate cancer progression

February 21, 2012
Genomic instability caused by an erosion of the protective caps on chromosomes, followed by activation of an enzyme that reinforces those caps, allows malignant cells to evade destruction and acquire more deadly characteristics, ...

Recommended for you

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.